News Agency
The Times

Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector

  • Written by PR Newswire
  • Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology clinical trials market
  • Genesis Capital is partnering with existing management to expand Crux into new testing and clinical trial streams

MELBOURNE,...

Read more: Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion